Filing Flows › Si-Bone (SIBN) › Q2 2026 › vs Q2 2025
Si-Bone (SIBN) Q2 2026 vs Q2 2025 (year over year)
Si-Bone's revenue rose $7.4M (+15%) from $48.6M in Q2 2025 to $56.0M in Q2 2026.
Si-Bone, Q2 2026: revenue $56.0M (+15% year over year), operating margin -8.6%, net loss $4.1M, operating cash flow $777K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $56.0M | $48.6M | $7.4M | +15% |
| Other income, net | $718K | $852K | −$134K | -16% |
| Net loss | $4.1M | $6.2M | −$2.1M | -34% |
| Costs & expenses | $60.8M | $55.6M | $5.2M | +9% |
| Operating costs | $60.8M | $55.6M | $5.2M | +9% |
| Cost of revenue | $11.5M | $9.8M | $1.6M | +17% |
| Research & development | $5.2M | $4.3M | $912K | +21% |
| Sales & marketing | $34.0M | $30.8M | $3.2M | +11% |
| General & admin | $10.1M | $10.7M | −$612K | -6% |
| Operating cash sources | $7.7M | $8.0M | −$368K | -5% |
| Depreciation & amortization | $1.7M | $1.4M | $311K | +23% |
| Share-based compensation | $6.0M | $6.7M | −$679K | -10% |
| Net loss absorbed | $4.1M | $6.2M | −$2.1M | -34% |
| Working capital & other | $2.8M | $1.7M | $1.1M | +64% |
| Operating cash flow | $777K | $173K | $604K | +349% |
| Capital expenditures | $1.5M | $2.1M | −$554K | -26% |
| Negative free cash flow (OCF − capex) | $768K | $1.9M | −$1.2M | -60% |
Questions
How much did Si-Bone's revenue grow year over year in Q2 2026?
Si-Bone's revenue rose $7.4M (+15%) from $48.6M in Q2 2025 to $56.0M in Q2 2026.